Esther Wei Yin Chang

机构：SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Medical School, National Cancer Centre Singapore · ORCID：0000-0003-3381-5102

发表论文 43 篇 · 总被引 391 次 · h-index 7

代表论文

• Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma (2024 · Journal of Hematology & Oncology · 被引 19)
• A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma (2022 · Cancers · 被引 16)
• Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma (2024 · Experimental Hematology and Oncology · 被引 10)
• Burkitt lymphoma – no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy (2022 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 10)
• Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study (2023 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 7)
• Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin’s Lymphoma (2023 · Hematology Reports · 被引 7)